Corcept Therapeutics CORT Operating margin

Operating margin at other companies

XER

Xeris Biopharma Holdings, Inc.XERS

10.9%+8.4pp

Crinetics PharmaceuticalsCRNX

-3,020.3%-1,463pp

ImmunomeIMNM

-5,947.9%-12,002pp

Arcus BiosciencesRCUS

-415.4%-756pp

Nektar TherapeuticsNKTR

-242%—

Madrigal Pharmaceuticals, Inc.MDGL

-25.1%-9.2pp

FAQ

What is Corcept Therapeutics's operating margin?

Corcept Therapeutics (CORT) reported operating margin of 0.8% in Q2 2026.

How has Corcept Therapeutics's operating margin changed year-over-year?

Corcept Therapeutics's operating margin decreased by 94.6% year-over-year, from 14.2% to 0.8%.

What is the long-term trend for Corcept Therapeutics's operating margin?

Over 5 years (2020 to 2025), Corcept Therapeutics's operating margin has grown at a -30.5% compound annual growth rate (CAGR), from 36.2% to 5.9%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.